首页> 外文期刊>International journal of infectious diseases : >Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure @? a case report and brief review of the literature
【24h】

Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure @? a case report and brief review of the literature

机译:HIV阳性慢性肾功能衰竭患者静脉注射喷他pen和口服氟康唑治疗内脏利什曼病。病例报告和文献简要回顾

获取原文
           

摘要

We report the case of an HIV-positive patient with visceral leishmaniasis and several relapses after treatment with the two first-line anti-leishmanial drugs, liposomal amphotericin B and miltefosine. End-stage renal failure occurred in 2007 when the patient was on long-term treatment with miltefosine. A relapse of leishmaniasis in 2008 was successfully treated with a novel combination regimen of intravenous pentamidine and oral fluconazole. Secondary prophylaxis with fluconazole monotherapy did not prevent parasitological relapse of leishmaniasis.
机译:我们报告了一例内脏利什曼病的HIV阳性患者,用两种一线抗利什曼病药物,脂质体两性霉素B和米替福辛治疗后复发。终末期肾衰竭发生在2007年,当时该患者接受米替福辛长期治疗。通过静脉内喷他tam和口服氟康唑的新型联合疗法成功治疗了2008年的利什曼病复发。氟康唑单一疗法的二级预防不能预防利什曼病的寄生虫学复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号